Application of Perfusion Imaging in the Telehealth Setting for Acute Ischemic Stroke-Reference-Cited by-同舟云学术

Application of Perfusion Imaging in the Telehealth Setting for Acute Ischemic Stroke

Published:2024-04 Issue:2 Volume:33 Page:37-46
ISSN:1028-768X
Container-title:Acta Neurologica Taiwanica
language:en
Short-container-title:

Author:

Valente Michael¹²³,Phan Thanh¹²,Parsons Mark⁴⁵⁶,Ma Henry¹²

Affiliation:

1. Department of Medicine, School of Clinical Science, Monash University, Melbourne, Victoria, Australia

2. Department of Neurology, Monash Health, Clayton, Victoria, Australia

3. Royal Melbourne Hospital, and Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia

4. Department of Neurology, Liverpool Hospital, University of New South Wales, Sydney, NSW, Australia

5. South Western Sydney Clinical School, Sydney, New South Wales, Australia

6. The Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia

Abstract

In the remote telehealth setting, computed tomography perfusion (CTP) provides important information in assessing the suitability of reperfusion therapy for patients with stroke syndromes. This review will discuss key concepts surrounding the use of CTP, including basic science, clinical applications, pitfalls, recent trials, and technical considerations. CTP can enhance decision-making for patients who are in the extended window from stroke onset, and this review will address key concepts relevant to its use.

Publisher

Medknow

Reference51 articles.

1. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke;Ma;N Engl J Med,2019

2. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging;Albers;N Engl J Med,2018

3. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct;Nogueira;N Engl J Med,2018

4. Quality and safety of Telemedicine in acute ischemic stroke: Early experience in Taiwan;Lin;J Formos Med Assoc,2022

5. Telestroke’s role through the COVID-19 pandemic and beyond;Harahsheh;Curr Treat Options Neurol,2022